Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinoma

Tyrosine kinase inhibitors (TKI) have improved prognosis in metastatic anaplastic lymphoma kinase (ALK)-driven lung adenocarcinoma, but patient outcomes vary widely. We retrospectively analyzed the clinical course of all cases with assessable baseline TP53 status and/or ALK fusion variant treated at...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Christopoulos, Petros (VerfasserIn) , Kirchner, Martina (VerfasserIn) , Bozorgmehr, Farastuk (VerfasserIn) , Endris, Volker (VerfasserIn) , El Sayed, Mei (VerfasserIn) , Budczies, Jan (VerfasserIn) , Ristau, Jonas (VerfasserIn) , Penzel, Roland (VerfasserIn) , Herth, Felix (VerfasserIn) , Heußel, Claus Peter (VerfasserIn) , Eichhorn, Martin E. (VerfasserIn) , Muley, Thomas (VerfasserIn) , Meister, Michael (VerfasserIn) , Rieken, Stefan (VerfasserIn) , Lasitschka, Felix (VerfasserIn) , Bischoff, Helge (VerfasserIn) , Sotillo, Rocio (VerfasserIn) , Schirmacher, Peter (VerfasserIn) , Thomas, Michael (VerfasserIn) , Stenzinger, Albrecht (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: [1 January 2019]
In: International journal of cancer
Year: 2019, Jahrgang: 144, Heft: 1, Pages: 190-199
ISSN:1097-0215
DOI:10.1002/ijc.31893
Online-Zugang:Verlag, Volltext: https://doi.org/10.1002/ijc.31893
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.31893
Volltext
Verfasserangaben:P. Christopoulos, M. Kirchner, F. Bozorgmehr, V. Endris, M. Elsayed, J. Budczies, J. Ristau, R. Penzel, F.J. Herth, C.P. Heussel, M. Eichhorn, T. Muley, M. Meister, J.R. Fischer, S. Rieken, F. Lasitschka, H. Bischoff, R. Sotillo, P. Schirmacher, M. Thomas, A. Stenzinger

MARC

LEADER 00000caa a2200000 c 4500
001 1664903720
003 DE-627
005 20220816145113.0
007 cr uuu---uuuuu
008 190507s2019 xx |||||o 00| ||eng c
024 7 |a 10.1002/ijc.31893  |2 doi 
035 |a (DE-627)1664903720 
035 |a (DE-599)KXP1664903720 
035 |a (OCoLC)1341212139 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
084 |a 33  |2 sdnb 
100 1 |a Christopoulos, Petros  |d 1977-  |e VerfasserIn  |0 (DE-588)138659702  |0 (DE-627)604886756  |0 (DE-576)308488067  |4 aut 
245 1 0 |a Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinoma  |c P. Christopoulos, M. Kirchner, F. Bozorgmehr, V. Endris, M. Elsayed, J. Budczies, J. Ristau, R. Penzel, F.J. Herth, C.P. Heussel, M. Eichhorn, T. Muley, M. Meister, J.R. Fischer, S. Rieken, F. Lasitschka, H. Bischoff, R. Sotillo, P. Schirmacher, M. Thomas, A. Stenzinger 
246 3 3 |a Identification of a highly lethal V3 + TP53 + subset in ALK + lung adenocarcinoma 
264 1 |c [1 January 2019] 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Die Pluszeichen sind im Titel hochgestellt 
500 |a First published: 26 September 2018 
500 |a Gesehen am07.05.2019 
520 |a Tyrosine kinase inhibitors (TKI) have improved prognosis in metastatic anaplastic lymphoma kinase (ALK)-driven lung adenocarcinoma, but patient outcomes vary widely. We retrospectively analyzed the clinical course of all cases with assessable baseline TP53 status and/or ALK fusion variant treated at our institutions (n = 102). TP53 mutations were present in 17/87 (20%) and the echinoderm microtubule-associated protein-like 4 (EML4)-ALK variant 3 (V3) in 41/92 (45%) patients. The number of metastatic sites at diagnosis was affected more by the presence of V3 than by TP53 mutations, and highest with both factors (mean 5.3, p < 0.001). Under treatment with ALK TKI, progression-free survival (PFS) was shorter with either TP53 mutations or V3, while double positive cases appeared to have an even higher risk (hazard ratio [HR] = 2.9, p = 0.015). The negative effect of V3 on PFS of TKI-treated patients was strong already in the first line (HR = 2.5, p = 0.037) and decreased subsequently, whereas a trend for PFS impairment under first-line TKI by TP53 mutations became stronger and statistically significant only when considering all treatment lines together. Overall survival was impaired more by TP53 mutations (HR = 4.9, p = 0.003) than by V3 (HR = 2.4, p = 0.018), while patients with TP53 mutated V3-driven tumors carried the highest risk of death (HR = 9.1, p = 0.02). Thus, TP53 mutations and V3 are independently associated with enhanced metastatic spread, shorter TKI responses and inferior overall survival in ALK+ lung adenocarcinoma. Both markers could assist selection of cases for more aggressive management and guide development of novel therapeutic strategies. In combination, they define a patient subset with very poor outcome. 
650 4 |a ALK+ NSCLC 
650 4 |a EML4-ALK fusion variant 
650 4 |a metastasis 
650 4 |a overall survival 
650 4 |a TP53 mutation 
650 4 |a treatment failure 
700 1 |a Kirchner, Martina  |d 1973-  |e VerfasserIn  |0 (DE-588)1017178976  |0 (DE-627)676266363  |0 (DE-576)353239747  |4 aut 
700 1 |a Bozorgmehr, Farastuk  |d 1979-  |e VerfasserIn  |0 (DE-588)141921811  |0 (DE-627)632526734  |0 (DE-576)326848150  |4 aut 
700 1 |a Endris, Volker  |e VerfasserIn  |0 (DE-588)1063753686  |0 (DE-627)812590961  |0 (DE-576)422898198  |4 aut 
700 1 |a El Sayed, Mei  |e VerfasserIn  |0 (DE-588)1185583343  |0 (DE-627)1664958355  |4 aut 
700 1 |a Budczies, Jan  |d 1970-  |e VerfasserIn  |0 (DE-588)124086403  |0 (DE-627)706532724  |0 (DE-576)186167679  |4 aut 
700 1 |a Ristau, Jonas  |d 1989-  |e VerfasserIn  |0 (DE-588)1075216303  |0 (DE-627)83302986X  |0 (DE-576)443326444  |4 aut 
700 1 |a Penzel, Roland  |e VerfasserIn  |0 (DE-588)102044021X  |0 (DE-627)691221316  |0 (DE-576)360421083  |4 aut 
700 1 |a Herth, Felix  |e VerfasserIn  |0 (DE-588)1016095236  |0 (DE-627)705477568  |0 (DE-576)351509925  |4 aut 
700 1 |a Heußel, Claus Peter  |e VerfasserIn  |0 (DE-588)1048631389  |0 (DE-627)780769422  |0 (DE-576)40288146X  |4 aut 
700 1 |a Eichhorn, Martin E.  |d 1974-  |e VerfasserIn  |0 (DE-588)124436900  |0 (DE-627)363346627  |0 (DE-576)294170545  |4 aut 
700 1 |a Muley, Thomas  |e VerfasserIn  |0 (DE-588)1056885432  |0 (DE-627)794179169  |0 (DE-576)16759284X  |4 aut 
700 1 |a Meister, Michael  |e VerfasserIn  |0 (DE-588)1078792046  |0 (DE-627)839461402  |0 (DE-576)451890108  |4 aut 
700 1 |a Rieken, Stefan  |d 1979-  |e VerfasserIn  |0 (DE-588)135553385  |0 (DE-627)567062570  |0 (DE-576)278641725  |4 aut 
700 1 |a Lasitschka, Felix  |d 1979-  |e VerfasserIn  |0 (DE-588)140496343  |0 (DE-627)618903542  |0 (DE-576)318526077  |4 aut 
700 1 |a Bischoff, Helge  |d 1958-  |e VerfasserIn  |0 (DE-588)111184576  |0 (DE-627)389658286  |0 (DE-576)167287249  |4 aut 
700 1 |a Sotillo, Rocio  |e VerfasserIn  |0 (DE-588)1185583602  |0 (DE-627)1664959114  |4 aut 
700 1 |a Schirmacher, Peter  |d 1961-  |e VerfasserIn  |0 (DE-588)1020440112  |0 (DE-627)691221197  |0 (DE-576)360427448  |4 aut 
700 1 |a Thomas, Michael  |e VerfasserIn  |0 (DE-588)1054438781  |0 (DE-627)79152213X  |0 (DE-576)41027089X  |4 aut 
700 1 |a Stenzinger, Albrecht  |e VerfasserIn  |0 (DE-588)139606106  |0 (DE-627)703395238  |0 (DE-576)312432755  |4 aut 
773 0 8 |i Enthalten in  |t International journal of cancer  |d Bognor Regis : Wiley-Liss, 1966  |g 144(2019), 1, Seite 190-199  |h Online-Ressource  |w (DE-627)269532781  |w (DE-600)1474822-8  |w (DE-576)079876129  |x 1097-0215  |7 nnas  |a Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinoma 
773 1 8 |g volume:144  |g year:2019  |g number:1  |g pages:190-199  |g extent:10  |a Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinoma 
856 4 0 |u https://doi.org/10.1002/ijc.31893  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.31893  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20190508 
992 |a 20190508 
993 |a Article 
993 |a Article 
994 |a 2019 
994 |a 2019 
998 |g 139606106  |a Stenzinger, Albrecht  |m 139606106:Stenzinger, Albrecht  |d 910000  |d 912000  |e 910000PS139606106  |e 912000PS139606106  |k 0/910000/  |k 1/910000/912000/  |p 21  |y j 
998 |g 1054438781  |a Thomas, Michael  |m 1054438781:Thomas, Michael  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PT1054438781  |e 950000PT1054438781  |e 950900PT1054438781  |e 50000PT1054438781  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 20 
998 |g 1020440112  |a Schirmacher, Peter  |m 1020440112:Schirmacher, Peter  |d 910000  |d 912000  |e 910000PS1020440112  |e 912000PS1020440112  |k 0/910000/  |k 1/910000/912000/  |p 19 
998 |g 1185583602  |a Sotillo, Rocio  |m 1185583602:Sotillo, Rocio  |d 140000  |e 140000PS1185583602  |k 0/140000/  |p 18 
998 |g 111184576  |a Bischoff, Helge  |m 111184576:Bischoff, Helge  |d 910000  |d 950000  |d 950900  |e 910000PB111184576  |e 950000PB111184576  |e 950900PB111184576  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 17 
998 |g 140496343  |a Lasitschka, Felix  |m 140496343:Lasitschka, Felix  |d 910000  |d 912000  |e 910000PL140496343  |e 912000PL140496343  |k 0/910000/  |k 1/910000/912000/  |p 16 
998 |g 135553385  |a Rieken, Stefan  |m 135553385:Rieken, Stefan  |d 910000  |d 911400  |e 910000PR135553385  |e 911400PR135553385  |k 0/910000/  |k 1/910000/911400/  |p 15 
998 |g 1078792046  |a Meister, Michael  |m 1078792046:Meister, Michael  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PM1078792046  |e 950000PM1078792046  |e 950900PM1078792046  |e 50000PM1078792046  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 13 
998 |g 1056885432  |a Muley, Thomas  |m 1056885432:Muley, Thomas  |d 910000  |d 950000  |d 950900  |e 910000PM1056885432  |e 950000PM1056885432  |e 950900PM1056885432  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 12 
998 |g 124436900  |a Eichhorn, Martin E.  |m 124436900:Eichhorn, Martin E.  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PE124436900  |e 950000PE124436900  |e 950900PE124436900  |e 50000PE124436900  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 11 
998 |g 1048631389  |a Heußel, Claus Peter  |m 1048631389:Heußel, Claus Peter  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PH1048631389  |e 950000PH1048631389  |e 950900PH1048631389  |e 50000PH1048631389  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 10 
998 |g 1016095236  |a Herth, Felix  |m 1016095236:Herth, Felix  |d 50000  |e 50000PH1016095236  |k 0/50000/  |p 9 
998 |g 102044021X  |a Penzel, Roland  |m 102044021X:Penzel, Roland  |d 910000  |d 912000  |e 910000PP102044021X  |e 912000PP102044021X  |k 0/910000/  |k 1/910000/912000/  |p 8 
998 |g 1075216303  |a Ristau, Jonas  |m 1075216303:Ristau, Jonas  |d 910000  |d 911400  |e 910000PR1075216303  |e 911400PR1075216303  |k 0/910000/  |k 1/910000/911400/  |p 7 
998 |g 124086403  |a Budczies, Jan  |m 124086403:Budczies, Jan  |d 910000  |d 912000  |e 910000PB124086403  |e 912000PB124086403  |k 0/910000/  |k 1/910000/912000/  |p 6 
998 |g 1185583343  |a El Sayed, Mei  |m 1185583343:El Sayed, Mei  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PE1185583343  |e 950000PE1185583343  |e 950900PE1185583343  |e 50000PE1185583343  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 5 
998 |g 1063753686  |a Endris, Volker  |m 1063753686:Endris, Volker  |d 910000  |d 912000  |e 910000PE1063753686  |e 912000PE1063753686  |k 0/910000/  |k 1/910000/912000/  |p 4 
998 |g 141921811  |a Bozorgmehr, Farastuk  |m 141921811:Bozorgmehr, Farastuk  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PB141921811  |e 950000PB141921811  |e 950900PB141921811  |e 50000PB141921811  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 3 
998 |g 1017178976  |a Kirchner, Martina  |m 1017178976:Kirchner, Martina  |p 2 
998 |g 138659702  |a Christopoulos, Petros  |m 138659702:Christopoulos, Petros  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PC138659702  |e 950000PC138659702  |e 950900PC138659702  |e 50000PC138659702  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1664903720  |e 3472110341 
999 |a KXP-PPN1664903720  |e 3472105755 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1664903720","origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"[1 January 2019]"}],"note":["Die Pluszeichen sind im Titel hochgestellt","First published: 26 September 2018","Gesehen am07.05.2019"],"id":{"eki":["1664903720"],"doi":["10.1002/ijc.31893"]},"language":["eng"],"name":{"displayForm":["P. Christopoulos, M. Kirchner, F. Bozorgmehr, V. Endris, M. Elsayed, J. Budczies, J. Ristau, R. Penzel, F.J. Herth, C.P. Heussel, M. Eichhorn, T. Muley, M. Meister, J.R. Fischer, S. Rieken, F. Lasitschka, H. Bischoff, R. Sotillo, P. Schirmacher, M. Thomas, A. Stenzinger"]},"relHost":[{"language":["eng"],"titleTranslated":[{"translated":"Journal international du cancer"}],"id":{"zdb":["1474822-8"],"eki":["269532781"],"issn":["1097-0215"],"doi":["10.1002/(ISSN)1097-0215"]},"pubHistory":["1.1966 -"],"note":["Gesehen am 28.02.08","Darin: Predictive oncology"],"origin":[{"publisherPlace":"Bognor Regis","publisher":"Wiley-Liss","dateIssuedDisp":"1966-","dateIssuedKey":"1966"}],"recId":"269532781","type":{"media":"Online-Ressource","bibl":"periodical"},"physDesc":[{"extent":"Online-Ressource"}],"disp":"Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinomaInternational journal of cancer","part":{"text":"144(2019), 1, Seite 190-199","year":"2019","pages":"190-199","issue":"1","volume":"144","extent":"10"},"title":[{"subtitle":"publication of the International Union against Cancer (UICC) = Journal international du cancer","title_sort":"International journal of cancer","title":"International journal of cancer"}],"corporate":[{"display":"International Union against Cancer","role":"isb"}],"titleAlt":[{"title":"Predictive oncology"}]}],"titleAlt":[{"title":"Identification of a highly lethal V3 + TP53 + subset in ALK + lung adenocarcinoma"}],"physDesc":[{"extent":"10 S."}],"title":[{"title_sort":"Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinoma","title":"Identification of a highly lethal V3+TP53+ subset in ALK+ lung adenocarcinoma"}],"person":[{"role":"aut","display":"Christopoulos, Petros","given":"Petros","family":"Christopoulos"},{"family":"Kirchner","role":"aut","given":"Martina","display":"Kirchner, Martina"},{"family":"Bozorgmehr","role":"aut","display":"Bozorgmehr, Farastuk","given":"Farastuk"},{"family":"Endris","role":"aut","given":"Volker","display":"Endris, Volker"},{"family":"El Sayed","display":"El Sayed, Mei","given":"Mei","role":"aut"},{"display":"Budczies, Jan","given":"Jan","role":"aut","family":"Budczies"},{"role":"aut","given":"Jonas","display":"Ristau, Jonas","family":"Ristau"},{"family":"Penzel","given":"Roland","display":"Penzel, Roland","role":"aut"},{"given":"Felix","display":"Herth, Felix","role":"aut","family":"Herth"},{"given":"Claus Peter","display":"Heußel, Claus Peter","role":"aut","family":"Heußel"},{"role":"aut","given":"Martin E.","display":"Eichhorn, Martin E.","family":"Eichhorn"},{"family":"Muley","given":"Thomas","display":"Muley, Thomas","role":"aut"},{"family":"Meister","role":"aut","display":"Meister, Michael","given":"Michael"},{"role":"aut","display":"Rieken, Stefan","given":"Stefan","family":"Rieken"},{"family":"Lasitschka","display":"Lasitschka, Felix","given":"Felix","role":"aut"},{"role":"aut","display":"Bischoff, Helge","given":"Helge","family":"Bischoff"},{"family":"Sotillo","given":"Rocio","display":"Sotillo, Rocio","role":"aut"},{"given":"Peter","display":"Schirmacher, Peter","role":"aut","family":"Schirmacher"},{"display":"Thomas, Michael","given":"Michael","role":"aut","family":"Thomas"},{"display":"Stenzinger, Albrecht","given":"Albrecht","role":"aut","family":"Stenzinger"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a CHRISTOPOUIDENTIFICA1201